Fairmount Funds Management LLC
CIK 0001802528
Annualised vol
18.670954%
Beta
0.138532
HHI
1390.627921
Top-10 weight
97.649702%
VaR 95%
1.559006%
VaR 99%
3.637964%
Max drawdown
50.365046%
Matched value
74.851736%
Returns of reported holdings
Loading returns…
Position changes vs prior quarter
What the latest 13F shows bought and sold against the quarter before, by share count.
| Ticker | Change | Shares now | Shares before | Share change % | Value now ($) |
|---|---|---|---|---|---|
| ORKA | UNCHANGED | 3,705,262 | 3,705,262 | 0.0% | 352,629,785 |
| DMRA | UNCHANGED | 8,713,000 | 8,713,000 | 0.0% | 226,625,130 |
| COGT | UNCHANGED | 5,503,418 | 5,503,418 | 0.0% | 212,982,277 |
| JBIO | UNCHANGED | 4,553,494 | 4,553,494 | 0.0% | 101,178,637 |
| ELVN | UNCHANGED | 1,855,644 | 1,855,644 | 0.0% | 94,173,933 |
| ZBIO | UNCHANGED | 2,359,025 | 2,359,025 | 0.0% | 59,872,055 |
| CBIO | UNCHANGED | 2,747,866 | 2,747,866 | 0.0% | 49,461,588 |
| FTH | NEW | 722,020 | - | - | 18,050,500 |
| IKT | UNCHANGED | 8,625,000 | 8,625,000 | 0.0% | 17,508,750 |
| SYRE | CLOSED OUT | 0 | 4,018,101 | -100.0% | 0 |
Holdings (latest quarter)
| Ticker | Change | Issuer | Class | CUSIP | Value ($) | Weight % | Shares |
|---|---|---|---|---|---|---|---|
| ORKA | UNCHANGED | ORUKA THERAPEUTICS INC | COM | 687604108 | 352,629,785 | 23.31 | 3705262.0 |
| - | DIANTHUS THERAPEUTICS INC | COM | 252828108 | 247,325,379 | 16.35 | 2537191.0 | |
| DMRA | UNCHANGED | DAMORA THERAPEUTICS INC | COM NEW | 36322Q206 | 226,625,130 | 14.98 | 8713000.0 |
| COGT | UNCHANGED | COGENT BIOSCIENCES INC | COM | 19240Q201 | 212,982,277 | 14.08 | 5503418.0 |
| JBIO | UNCHANGED | JADE BIOSCIENCES INC | COM NEW | 008064206 | 101,178,637 | 6.69 | 4553494.0 |
| ELVN | UNCHANGED | ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 94,173,933 | 6.22 | 1855644.0 |
| - | VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 93,520,347 | 6.18 | 5090928.0 | |
| ZBIO | UNCHANGED | ZENAS BIOPHARMA INC | COM | 98937L105 | 59,872,055 | 3.96 | 2359025.0 |
| CBIO | UNCHANGED | CRESCENT BIOPHARMA INC. | COM | G2545C104 | 49,461,588 | 3.27 | 2747866.0 |
| - | APOGEE THERAPEUTICS INC | COM | 03770N101 | 39,639,416 | 2.62 | 298647.0 | |
| FTH | NEW | FAETH THERAPEUTICS INC | COM NEW | 81728A207 | 18,050,500 | 1.19 | 722020.0 |
| IKT | UNCHANGED | INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | 17,508,750 | 1.16 | 8625000.0 |
Quarterly portfolios
| Period | Filed | Value ($) | Positions | Vol % | Beta | Max DD % |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | 1,512,967,797 | 12 | 18.670954 | 0.138532 | 50.365046 |
| 2026-03-31 | 2026-05-15 | 1,384,339,432 | 12 | 19.312364 | 0.157565 | 51.33867 |
| 2025-12-31 | 2026-02-17 | 1,313,784,318 | 13 | 15.294629 | 0.124856 | 43.200078 |
| 2025-09-30 | 2025-11-14 | 1,111,423,463 | 17 | 11.84169 | 0.155885 | 28.007582 |
| 2025-03-31 | 2025-05-15 | 644,620,652 | 15 | 14.451744 | 0.202787 | 24.933924 |
| 2024-12-31 | 2025-02-14 | 1,005,884,370 | 17 | 12.665367 | 0.177355 | 24.735574 |